Luke Miels

Luke Miels is a declared insider of GSK plc, with filings sourced from RNS (LSE). The record holds 62 filings, for trades running from 12 October 2023 to 12 October 2026.

No open-market purchase appears, only 7 sales worth €1.3M. The totals exclude 1 filing filed without an amount. Besides market trades, the filings include 55 share grants. So far in 2026, the count stands at no purchases and 2 sales.

The latest filing, published on 14 October 2026, reports a share grant of €29k in GSK plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 4 days. For comparison, UK MAR gives managers three business days to notify a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.